Study Links Glitazone Diabetes Drugs Avandia & Actos To Severe Vision Problems
A new study in the April 2009 issue of the American Journal of Ophthalmology (AJO) has linked a group of glitazone diabetes drugs to an increased risk of developing diabetic macular edema, or DME. Popular diabetes drugs such ...

More Diabetic Patients Sue GlaxoSmithKline Over Avandia Injuries
GlaxoSmithKline (GSK) has faced hundreds of lawsuits over its diabetes drug, Avandia, over the past few years. Now, two more diabetic patients are suing the pharmaceutical giant after suffering a stroke and a heart attack wh ...

New Study Shows Senior Avandia Patients At Greater Risk Of Heart Failure & Deat
A new study by the Canada's Ontario Ministry of Health & Long Term Care published in the British Medical Journal shows that senior patients taking GlaxoSmithKline's diabetes drug Avandia (rosiglitazone) were at a greater risk ...

FDA Claims Glaxo Withheld Avandia Studies
The U.S. Food and Drug Administration (FDA) claims that GlaxoSmithKline, PLC withheld nine studies related to Avandia, its popular diabetes drug, after an inspection of the company’s North Carolina offices. Research has lin ...

Consumer Group Says GlaxoSmithKline's Avandia Should Be Banned
The consumer group Public Citizen says that Avandia, GlaxoSmithKline's popular medication for Type 2 diabetes, should be banned as more and more cases of liver toxicity are being linked to the drug's use.

University Study Reports Avandia & Actos Double The Risk Of Bone Fractures
A new medical university study has reported that women who take GlaxoSmithKline's Avandia or Takeda Pharmaceutical's Actos, both drugs which treat Type 2 diabetes, could double their risk of bone fractures. Results of the st ...

Study Provides Further Proof of Avandia’s Heart Risks
A new Canadian study conducted by an independent firm recently reported that patients taking the popular diabetes drug, Avandia, had a higher incidence of heart attacks, death and congestive heart failure.

Avandia Being Dropped By Major Pharmacies
Avandia, the popular medication for Type 2 diabetes, is being dropped by at least two major pharmaceutical companies – a further sign that the drug’s reported increase of heart risk may be taking its toll.

FDA To Hear Glaxo's Findings on Avandia
The FDA will hear GlaxoSmithKline’s findings on the drug Avandia on July 30, 2007. The drug has come under fire for reportedly increasing the risk of heart attacks to those who use it.

Panel Advises FDA to Keep Avandia on Shelves
An advisory committee has recommended that the FDA keep the diabetes drug, Avandia, on the market with increased warnings until further research can be done.

Avandia Linked To Increase In Heart Attacks
The popular diabetes drug, Avandia, has been linked to an increased number of heart attacks according to a safety alert issued by the U.S. Food and Drug Administration (FDA) on May 21, 2007.

New England Journal Of Medicine Reports Avandia Increases Heart Attack Risk By 43%
The New England Journal of Medicine reported on May 21, 2007 that using Avandia, a drug prescribed for diabetics, increases the risk of a heart attack by 43%. Avandia has been on the market since 1999 and is prescribed to ne ...